No connection

Search Results

AMTB

NEUTRAL
$22.82 Live
Amerant Bancorp Inc. · NYSE
Target $25.25 (+10.6%)
$15.62 52W Range $24.38

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$958.36M
P/E
16.07
ROE
6.4%
Profit margin
14.6%
Debt/Equity
N/A
Dividend yield
1.58%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
AMTB presents a stark contrast between attractive valuation and deteriorating fundamental health. While the stock trades below its Graham Number ($27.18) and Intrinsic Value ($41.89), the Piotroski F-Score of 2/9 indicates significant weakness in financial health. Strong year-over-year earnings growth (57.10%) is offset by sluggish revenue growth (3.30%) and a highly bearish technical trend (10/100). The company is essentially trading at book value (P/B 0.99), making it a value play with high fundamental risk.

Key Strengths

Trading below Graham Number ($27.18) and Intrinsic Value ($41.89)
Strong YoY Earnings Growth of 57.10%
Low Price-to-Book ratio (0.99) suggesting fair asset pricing
Conservative dividend payout ratio (25.35%)
Positive analyst consensus with a target price of $25.25

Key Risks

Critical Piotroski F-Score of 2/9 indicating weak financial health
Very bearish technical trend (10/100)
Low Return on Equity (6.41%) and Return on Assets (0.58%)
Stagnant organic revenue growth (3.30% YoY)
High volatility in quarterly earnings surprises
AI Fair Value Estimate
Based on comprehensive analysis
$27.18
+19.1% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
57
Moderate
Value
85
Future
60
Past
70
Health
20
Dividend
50
AI Verdict
Value Trap Risk
Key drivers: Low Piotroski Score, Deep Value Valuation, Bearish Technicals, Strong EPS Growth
Confidence
90%
Value
85/100

Ref P/E 16.07, Graham Number $27.18, P/B 0.99

Positives
  • Price < Graham Number
  • Price < Intrinsic Value
  • P/B < 1.0
Watchpoints
  • P/E is moderate at 16.07
Future
60/100

Ref Growth rates and Forward P/E

Positives
  • High YoY Earnings Growth (57.10%)
  • Forward P/E (9.83) is lower than current P/E
Watchpoints
  • Weak Revenue Growth (3.30%)
  • Recent Q/Q EPS decline (-17.0%)
Past
70/100

Ref Historical price performance

Positives
  • Strong 1Y price change (+37.3%)
  • Consistent long-term growth (5Y +35.7%)
Watchpoints
  • Inconsistent quarterly earnings beats
Health
20/100

Ref Piotroski F-Score

Positives
  • No Altman Z-Score distress indicated
Watchpoints
  • Piotroski F-Score 2/9 is critically weak
Dividend
50/100

Ref Yield and Payout

Positives
  • Sustainable payout ratio (25.35%)
Watchpoints
  • Low dividend yield (1.58%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$22.82
Analyst Target
$25.25
Upside/Downside
+10.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AMTB and closest competitors.

Updated 2026-04-24
AMT
Amerant Bancorp Inc.
Primary
5Y
+35.7%
3Y
+32.5%
1Y
+37.3%
6M
+31.1%
1M
+5.5%
1W
-4.2%
BBD
Barings BDC, Inc.
Peer
5Y
+71.2%
3Y
+50.1%
1Y
+5.0%
6M
+1.6%
1M
+3.4%
1W
-0.8%
ABT
American Bitcoin Corp
Peer
5Y
-100.0%
3Y
-98.8%
1Y
+7.2%
6M
-86.8%
1M
-9.6%
1W
-4.6%
BHR
Burke & Herbert Financial Services Corp.
Peer
5Y
+55.6%
3Y
-8.1%
1Y
+30.8%
6M
+7.6%
1M
+4.5%
1W
-0.9%
BCX
Blackrock Resources & Commodities Strategy Trust
Peer
5Y
+111.1%
3Y
+48.6%
1Y
+46.8%
6M
+32.6%
1M
+13.7%
1W
+5.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
16.07
Forward P/E
9.83
PEG Ratio
N/A
P/B Ratio
0.99
P/S Ratio
2.4
EV/Revenue
4.19
EV/EBITDA
N/A
Market Cap
$958.36M

Profitability

Profit margins and return metrics

Profit Margin 14.6%
Operating Margin 30.47%
Gross Margin N/A
ROE 6.41%
ROA 0.58%

Growth

Revenue and earnings growth rates

Revenue Growth +3.3%
Earnings Growth +57.1%
Q/Q Revenue Growth +13.96%
Q/Q Earnings Growth +49.5%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$4.68

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-22
$N/A
2026-04-23
$0.44
+1.1% surprise
2026-01-22
$0.53
+49.3% surprise
2025-10-28
$0.39
-26.4% surprise

Financial Services Sector Comparison

Comparing AMTB against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
16.07
This Stock
vs
36.01
Sector Avg
-55.4% (Discount)
Return on Equity (ROE)
6.41%
This Stock
vs
-0.73%
Sector Avg
-974.6% (Below Avg)
Profit Margin
14.6%
This Stock
vs
91.62%
Sector Avg
-84.1% (Weaker)
Revenue Growth
3.3%
This Stock
vs
35.27%
Sector Avg
-90.6% (Slower)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

NURSEY MICHAEL E.
Officer
Stock Award
2026-03-03
800 shares
CAPRILES ALBERTO
Officer
Stock Award
2026-02-18
1,964 shares
IAFIGLIOLA CARLOS
Officer
Stock Award
2026-02-18
2,307 shares
FLEITAS ARMANDO
Officer
Stock Award
2026-02-18
833 shares
SANCHEZ MARIOLA TRIANA
Officer
Stock Award
2026-02-18
1,740 shares
CALDERON SHARYMAR
Chief Financial Officer
Stock Award
2026-02-18
2,490 shares
PARRA PEDRO
Officer
Stock Award
2026-02-18
666 shares
NURSEY MICHAEL E.
Officer
Stock Award
2026-02-18
666 shares
EELMAN ANTHONY J
Officer
Stock Award
2026-02-18
333 shares
RODRIGUEZ ADRIAN J.
Officer
Stock Award
2026-02-18
833 shares
CAPRILES ALBERTO
Officer
Stock Award
2026-02-17
3,656 shares
IAFIGLIOLA CARLOS
Chief Executive Officer
Stock Award
2026-02-17
3,942 shares
FLEITAS ARMANDO
Officer
Stock Award
2026-02-17
1,667 shares
SANCHEZ MARIOLA TRIANA
Officer
Stock Award
2026-02-17
2,928 shares
CALDERON SHARYMAR
Chief Financial Officer
Stock Award
2026-02-17
3,057 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-23

AMTB filed an 8-K on April 23, 2026, likely to announce its first-quarter financial results.

DEF 14A
DEF 14A
2026-04-21

AMTB filed a Definitive Proxy Statement on April 21, 2026, providing shareholders with necessary information to vote on matters at the company's upcoming annual meeting.

8-K
8-K
2026-04-10

AMTB filed an 8-K on April 10, 2026, likely to announce its first-quarter financial results.

10-K
10-K
2026-02-27

AMTB filed its annual 10-K on February 27, 2026, which includes disclosures on its business operations, risk factors, and management's discussion and analysis. Specific financial highlights and risk details were not provided in the available excerpts.

8-K
8-K
2026-02-11

AMTB filed an 8-K on February 11, 2026, likely to announce its quarterly or annual financial results.

8-K
8-K
2026-01-22

AMTB filed an 8-K on January 22, 2026, likely to announce its fourth quarter and full-year financial results.

8-K
8-K
2026-01-07
8-K
8-K
2025-12-31

AMTB filed an 8-K on December 31, 2025, likely reporting year-end financial results or corporate governance updates.

8-K/A
8-K/A
2025-12-01

AMTB filed an amendment to a previously submitted Current Report on Form 8-K.

8-K/A
8-K/A
2025-11-17

AMTB filed an amendment to a previously submitted Form 8-K on November 17, 2025.

8-K
8-K
2025-11-10

AMTB filed an 8-K, likely reporting its third-quarter financial results.

8-K
8-K
2025-11-06

AMTB filed an 8-K on November 6, 2025, likely to announce its third-quarter financial results.

10-Q
10-Q
2025-10-31

Amerant (AMTB) is pursuing an aggressive growth strategy through the expansion of its Florida banking network, opening new centers in West Palm Beach, Miami Beach, and Tampa, with a St Petersburg location planned for 2026. The company is strengthening its commercial banking capabilities by hiring new leadership in C&I and loan syndications to drive loan growth. Specific financial metrics and risk factors were not detailed in the provided excerpts.

8-K
8-K
2025-10-28

AMTB filed an 8-K on October 28, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-10-22

AMTB filed an 8-K on October 22, 2025, likely to announce its third-quarter financial results.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
4 analysts
Keefe, Bruyette & Woods
2026-01-28
Maintains
Market Perform Market Perform
Piper Sandler
2026-01-26
Maintains
Overweight Overweight
Raymond James
2026-01-07
Maintains
Outperform Outperform
Keefe, Bruyette & Woods
2025-11-03
Maintains
Market Perform Market Perform
Raymond James
2025-10-29
up
Market Perform Outperform
Piper Sandler
2025-10-29
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning AMTB from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile